Clinical value of the quantitative expression of the three epitopes of CD34 in 300 cases of acute myeloid leukemia

Haematologica

Volumn 87, Issue 8, 2002, Pages 795-803

  Maynadié, Marc ^a   Gerland, Luc ^a   Aho, Serge ^a   Girodon, François ^a   Bernier, Michel ^a   Brunet, Corinne ^a   Campos, Lydia ^a   Daliphard, Sylvie ^a   Deneys, Véronique ^a   Falkenrodt, Annie ^a   Jacob, Marie Christine ^a   Kühlein, Emilienne ^a   Lecalvez, Geneviève ^a   Moskovtchenko, Philippe ^a   Philip, Patrick ^a   Carli, Paule Marie ^a   Faure, Gilbert C ^a   Béné, Marie Christine ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Acute myeloid leukemia; CD34; Prognosis; Quantification

Indexed keywords

CD34 ANTIGEN; CHYMOPAPAIN; EPITOPE; GLYCOPROTEIN; MONOCLONAL ANTIBODY; TUMOR ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ARTICLE; BLAST TRANSFORMATION; DIAGNOSTIC VALUE; ENDOTHELIUM CELL; GLYCOSYLATION; KARYOTYPE; MANNHEIMIA HAEMOLYTICA; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STEM CELL; VASCULAR ENDOTHELIUM; ACUTE DISEASE; CALIBRATION; CANCER STEM CELL; CLASSIFICATION; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FLOW CYTOMETRY; FLUOROMETRY; FOLLOW UP; FRANCE; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; INSTRUMENTATION; LIFE TABLE; METHODOLOGY; MORTALITY; MULTICENTER STUDY; MYELOID LEUKEMIA; PATHOLOGY; PHILADELPHIA 1 CHROMOSOME; PROGNOSIS; PROSPECTIVE STUDY; REPRODUCIBILITY; STANDARD;

ACUTE DISEASE; ANTIGENS, CD34; ANTIGENS, NEOPLASM; CALIBRATION; DISEASE-FREE SURVIVAL; EPITOPES; FLOW CYTOMETRY; FLUOROMETRY; FOLLOW-UP STUDIES; FRANCE; HUMAN; IMMUNOPHENOTYPING; LEUKEMIA, MYELOID; LIFE TABLES; PHILADELPHIA CHROMOSOME; PROGNOSIS; PROSPECTIVE STUDIES; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SUPPORT, NON-U.S. GOV'T; TUMOR STEM CELLS; HUMANS;

EID: 0035986753     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony- forming cells and their precursors
2. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells
3. Binding of L-selectin to the vascular sialomucin CD34
4. M10 CD34 cluster workshop section
5. Structural and partial amino acid sequence analysis of the human hemopoietic progenitor cell antigen CD34
6. The CD34 antigen: Structure, biology, and potential clinical applications
7. Differential sensitivity of CD34 epitopes to cleavage by Pasteurella haemolytica glycoprotease: Implications for purification of CD34-positive progenitor cells
8. Global vascular expression of murine CD34, a sialomucin-like endothelial ligand for L-selectin
9. Concordant expression of class II and class III CD34 epitopes on haemopoietic cells in leukapheresis and cord blood samples with CD45/CD34 dual staining
10. Extent of variability inherent in measurements of CD34-positive cells in different human haemopoietic tissues
11. Comparative analysis of class I, II and III epitopedetecting CD34 monoclonal antibodies by quantitative flow cytometry
12. Differences in the distribution of CD34 epitopes on normal haemopoietic progenitor cells and leukaemic blast cells
13. CD34 molecule epitope distribution on cells of haematopoietic origin
14. Expression of class I, II and III epitopes of the CD34 antigen by normal and leukemic hemopoietic cells
15. + cells: Methodology and monoclonal antibodies
16. + leukemic cells assessed by different CD34 monoclonal antibodies
17. Assessment of distribution of CD34 epitope classes in fresh and cryopreserved peripheral blood progenitor cells and acute myeloid leukemic blasts
18. Leukemia-associated changes identified by quantitative flow cytometry. IV. CD34 overexpression in acute myelogenous leukemia M2 with t(8;21)
19. Prognostic value of immunophenotypic characteristics of blast cells in acute myeloid leukemia
20. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group
21. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO)
22. Proposals for the immunological classification of acute leukemias
23. A new approach of acute lymphoblastic leukemia immunophenotypic classification: 1984-1994 the GEIL experience
24. Immunophenotypic patterns and cytogenetic anomalies in acute non-lymphoblastic leukemia subtypes: A prospective study of 432 patients
25. Should comparison be made between survival of responding vs. non-responding patients?
26. CD34: Structure, biology, and clinical utility
27. Antigenic analysis of hematopoiesis. V. Characterization of My-10 antigen expression by normal lymphohematopoietic progenitor cells
28. Clinicopathologic and cytogenic features of CD34 (My 10)-positive acute nonlymphocytic leukemia
29. Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: The significance of the stem-cell glycoprotein CD34 (My10)
30. Standardized multicentric quantimetry of differentiation antigens expression. The GEIL's approach in acute lymphoblastic leukemia
31. Quantitative fluorescence flow cytometry: A comparison of the three techniques for direct and indirect immunofluorescence
32. +/ DR-phenotypes with shorter survival
33. CD34 expression in de novo acute myeloid leukaemia
34. Impact of immunophenotyping on management of acute leukemias